Target intelligence / Profile preview

Cellular oxidative pathways

Molecular classification
Other (Encompasses enzymes, protein complexes, transporters, signaling mediators)
01

Overview

Cellular oxidative pathways refer to the ensemble of biological processes in which cells utilize oxidation-reduction reactions for energy production, metabolism, and signal transduction. The most prominent example is **oxidative phosphorylation**, where nutrients are oxidized in mitochondria, producing ATP and generating ROS as by-products[1][5]. Other pathways include the enzymatic generation and scavenging of ROS in various cell compartments. While these pathways are central to homeostasis, dysregulation leads to **oxidative stress**, contributing to aging, neurodegeneration, cancer, cardiovascular disease, and other disorders, and are thus a focus of many therapeutic approaches[4][6][7].\n\n**Note:** \"Cellular oxidative pathways\" is a functional/system-level concept, not a canonical single drug target, receptor, enzyme, or protein. If you need information about a **specific protein target within these pathways** (e.g., NADPH oxidase, mitochondrial complex I, or a particular ROS enzyme), please clarify.

Other names
Cellular redox pathwaysCellular oxidation pathwaysOxidative metabolismMitochondrial oxidative phosphorylation (subset)Electron transport chain (subset)ROS pathways (subset)
02

Mechanism of action

Scavenging ROS (antioxidants)\n- Inhibiting mitochondrial electron transport (complex inhibitors)\n- Modulating redox-sensitive signaling pathways (e.g., Nrf2 activators)

03

Biological functions

Energy production (ATP generation)Redox homeostasisSignal transduction (redox signaling)ApoptosisCell proliferationInflammationAutophagy regulationMaintenance of metabolic homeostasis
04

Disease associations

Neurodegenerative disease (e.g., Alzheimer's, Parkinson's)CancerCardiovascular diseaseDiabetesInflammatory diseaseAging and senescence
05

Safety considerations

Non-specific modulation risks (widespread systemic effects)Disruption of physiological ROS signalingCellular toxicity with excessive inhibition or activation
06

Interacting drugs

Antioxidants (Vitamin E, N-acetylcysteine)

2 more in the full profile.

07

Biomarkers

ROS levels (e.g., H₂O₂, superoxide)Redox state indicators (GSH/GSSG ratio)Oxidative damage markers (e.g., 8-oxo-dG for DNA oxidation)Mitochondrial function assays

Beyond the preview

Go deeper on Cellular oxidative pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular oxidative pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call